CD19 (Tafasitamab) Recombinant Monoclonal Antibody
Product Specifications
Gene Aliases
Antibody deficiency due to defect in CD19 antibody; Antibody deficiency due to defect in CD19; included antibody; AW495831 antibody; B lymphocyte antigen CD19 antibody; B lymphocyte surface antigen B4 antibody; B-lymphocyte antigen CD19 antibody; B-lymphocyte surface antigen B4 antibody; B4 antibody; CD19 antibody; CD19 antigen antibody; CD19 molecule antibody; Cd19 protein antibody; CD19_HUMAN antibody; CVID3 antibody; Differentiation antigen CD19 antibody; Leu 12 antibody; Leu-12 antibody; Leu12 antibody; MGC109570 antibody; MGC12802 antibody; T-cell surface antigen Leu-12 antibody; Tafasitamab
UniProt
P15391
Antigen Species
Human
Reactivity
Human
Target Antigen
Recombinant Human CD19 protein
Target
CD19
Clonality
Monoclonal
Conjugation
Non-conjugated
Field of Research
Immunology; Stem cells
Purification Method
Affinity-chromatography
Form
Liquid
Storage Conditions
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Antibody Type
Recombinant Antibody
Clone ID
12G5
Tested Applications
FC; Recommended dilution: FC:1:50-1:200
Isotype
IgG1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M3411-02A-ML405 100 µL
MTHFD1, ID (P550) (C-1-tetrahydrofolate Synthase, Cytoplasmic, C1-THF Synthase, Methylenetetrahydrofolate Dehydrogenase, Methenyltetrahydrofolate Cyclohydrolase, Formyltetrahydrofolate Synthetase, MTHFC, MTHFD) (MaxLight 405) discontinued
Ask
View Details 
211966-01 50 µL
MEF2A, phosphorylated (T312) (Myocyte-specific Enhancer Factor 2A, Mef2, ADCAD1, RSRFC4, RSRFC9) discontinued
Ask
View Details 211966-02 100 µL
MEF2A, phosphorylated (T312) (Myocyte-specific Enhancer Factor 2A, Mef2, ADCAD1, RSRFC4, RSRFC9) discontinued
Ask
View Details 211966-03 200 µL
MEF2A, phosphorylated (T312) (Myocyte-specific Enhancer Factor 2A, Mef2, ADCAD1, RSRFC4, RSRFC9) discontinued
Ask
View Details